ISLAMABAD, AUGUST 7: Investors were notified by the Pakistan Stock Exchange on Wednesday that BF Biosciences Limited has submitted an application to be listed on the Main Board of PSX.
Using the Book Building Method, a total of 25 million ordinary shares with a par value of Rs. 3 each will be issued in the Initial Public Offering, with a floor price of Rs. 55/-per share. The issue’s lead manager is Arif Habib Limited.
The Securities & Exchange Commission of Pakistan (SECP) has told us via Circular No. 16 of 2023, dated November 08, 2023, that the company’s draft prospectus is now available on the PSX website with the description “Public Comments on Draft Prospectus of BF Biosciences Limited.”
You can check the attached draft of the company’s prospectus for more information about the issue.
